Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs.

Area of Science:

• Biochemistry
• Molecular Biology
• Genomics

Background:

• MicroRNAs (miRNAs) are vital biomarkers for disease detection.
• Standardized, sensitive quantification methods are essential for clinical miRNA applications, especially in plasma.
• Low starting RNA amounts pose challenges for accurate miRNA profiling.

Purpose of the Study:

• To identify the most accurate method for quantifying microRNAs (miRNAs) in human plasma.
• To validate a hybridization platform's performance with reduced starting RNA amounts.
• To assess the reliability of different quantification platforms for low-concentration plasma samples.

Main Methods:

• Quantification of isolated miRNAs from plasma and reference samples using four platforms.
• Profiling of miRNAs via hybridization arrays and RNA sequencing (RNA-seq).
• Evaluation of spectrophotometers, a bioanalyzer, a fluorometer, and RNA-seq for miRNA measurement.

Main Results:

• Spectrophotometers (Infinite 200 PRO Nanoquant, Nanodrop 2000) overestimated miRNA concentration due to contaminants.
• Agilent 2100 Bioanalyzer provided RNA profile information but lacked quantification reliability for plasma.
• Qubit 2.0 Fluorometer offered the most accurate miRNA quantification; RNA-seq revealed ~58% of plasma small RNAs are true miRNAs.
• Reducing starting RNA by 30% for array profiling yielded comparable results to the full amount; 50% reduction was not sufficient.

Conclusions:

• The Qubit 2.0 Fluorometer is the preferred method for accurate miRNA quantification in plasma.
• Hybridization array profiling is robust with up to a 30% reduction in starting RNA input.
• Standardized protocols are critical for reliable miRNA biomarker discovery and clinical translation.